Haemonetics Corporation (HAE) Q3 2008 Earnings Results

Haemonetics Corp Reports EPS of $0.54, Stock Up 8.31%

Haemonetics Corp's earnings report showed an EPS of $0.54, which met expectations, leading to a positive stock reaction with an increase of 8.31%. The stock rise suggests investor confidence, although no revenue figures were disclosed. The management's focus on operational stability may have reassured investors amid a lack of guidance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.54	N/A	+0.00%

Management

Management commentary

Tone: Neutral

Overall, management expressed a steady outlook without providing specific guidance. They emphasized their focus on operational improvements.

Management highlighted the stability in their operations.

They noted ongoing efforts to improve efficiency.

Haemonetics Corp Reports EPS of $0.54, Stock Up 8.31%

Key numbers

Management commentary

Haemonetics Corporation

More earnings this week

Haemonetics Corp Reports EPS of $0.54, Stock Up 8.31%

Key numbers

Management commentary